Skip to main navigation Skip to search Skip to main content

Regulation of Circulating 1α,25-Dihydroxyvitamin D in β-Thalassemia

  • P. Dandona
  • , R. K. Menon
  • , S. Houlder
  • , M. Thomas
  • , D. M. Flynn
  • Royal Free London NHS Foundation Trust

Research output: Contribution to journalLetterpeer-review

Abstract

To the Editor: The letter by Bell and colleagues (November 28 issue)* demonstrating that black children in the United States maintain very tight concentrations of 1α,25-dihydroxyvitamin D despite alterations in concentrations of 25-hydroxyvitamin D prompts us to write about our observations in patients with β-thalassemia major and iron overload. In a study of 15 patients with this condition, we found a marked seasonal variation in serum concentrations of 25-hydroxyvitamin D. However, there were no changes in the concentrations of calcium, 1α,25-dihydroxyvitamin D, or parathyroid hormone (Table 1). Patients with β-thalassemia in the United Kingdom have marginal vitamin D nutrition, probably., No extract is available for articles shorter than 400 words.

Original languageEnglish
Pages (from-to)715-716
Number of pages2
JournalNew England Journal of Medicine
Volume314
Issue number11
DOIs
StatePublished - Mar 13 1986

Fingerprint

Dive into the research topics of 'Regulation of Circulating 1α,25-Dihydroxyvitamin D in β-Thalassemia'. Together they form a unique fingerprint.

Cite this